IP Library Assignment 068105/0767
Patent Assignment
Reel/Frame 068105/0767

Change of Address

Recorded: 2024-07-03 Pages: 6
Assignor
SANOFI
Executed: 2024-04-16
Assignee
SANOFI
46 AVENUE DE LA GRANDE ARMÉE, PARIS, 75017, FRANCE
Covered Properties (87)
Derivatives of 7 Alkynyl-1,8 Naphthyridones, Preparation Method Thereof and Use of Same in Therapeutics
Patent: 8,586,602 →
Application: 13/486,414 →
Publication: US US20120238598A1
Anti-CEACAM5 Antibodies and Uses Thereof
Application: 17/705,016 →
Publication: US US20220340682A1
Stabilized Pharmaceutical Formulations of Insulin Analogues and/or Insulin Derivatives
Application: 17/864,645 →
Publication: US US20230049480A1
Treatment of Diabetes Mellitus by Long-Acting Formulations of Insulins
Application: 17/540,448 →
Publication: US US20220202711A1
Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof
Application: 17/843,777 →
Publication: US US20230015181A1
Long-Acting Formulations of Insulin
Application: 17/176,442 →
Publication: US US20210308225A1
Combination Comprising Palbociclib and 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-Yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7] Annulene-2-Carboxylic Acid and Its Use for the Treatment of Cancer
Application: 17/579,187 →
Publication: US US20220362248A1
Long-Acting Formulations of Insulin
Application: 16/572,850 →
Publication: US US20200215163A1
Methods for Treating Inflammation Using Antibodies to Kallidin and Des-ARG10-Kallidin
Application: 18/063,981 →
Publication: US US20230399388A1
Bivalent, Bispecific Binding Proteins for Prevention or Treatment of Hiv Infection
Application: 18/458,060 →
Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
Application: 17/135,529 →
Publication: US US20210189011A1
Substituted Pyrido[3,4-B]Indoles for the Treatment of Cartilage Disorders
Application: 17/409,513 →
Publication: US US20220041596A1
Acylamino-Substituted Fused Cyclopentanecarboxylic Acid Derivatives and Their Use as Pharmaceuticals
Patent: 8,362,073 →
Application: 12/939,650 →
Publication: US US20110152290A1
Solid Pharmaceutical Fixed Dose Compositions Comprising Irbesartan and Amlodipine, Their Preparation and Their Therapeutic Application
Patent: 9,173,848 →
Application: 13/381,534 →
Publication: US US20120171288A1
Salts of Methyl 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylate and Preparation Process Thereof
Application: 17/193,776 →
Publication: US US20210188772A1
Antitumors Combinations Containing Antibodies Recognizing Specifically CD38 And Bortezomib
Patent: 9,314,522 →
Application: 13/992,684 →
Publication: US US20140186337A1
Fused Pyrroledicarboxamides and Their Use as Pharmaceuticals
Patent: 9,284,333 →
Application: 14/375,273 →
Publication: US US20150018342A1
Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for Their Preparation and Therapeutic Uses Thereof
Application: 15/613,689 →
Publication: US US20180079720A1
Acylamino-Substituted Fused Cyclopentanecarboxylic Acid Derivatives and Their Use as Pharmaceuticals
Patent: 8,802,720 →
Application: 13/867,293 →
Publication: US US20130225605A1
Process for the Preparation of Methyl 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylate
Application: 17/193,706 →
Publication: US US20210188771A1
Methods for Characterizing Compositions Comprising Peanut Antigens
Application: 17/523,050 →
Publication: US US20220170942A1
Acylamino-Substituted Fused Cyclopentanecarboxylic Acid Derivatives and Their Use as Pharmaceuticals
Patent: 8,445,530 →
Application: 13/632,546 →
Publication: US US20130030008A1
Use of Vegfr-3 Inhibitors for Treating Hepatocellular Carcinoma
Patent: 9,376,432 →
Application: 14/414,209 →
Publication: US US20150183780A1
Acylamino-Substituted Fused Cyclopentanecarboxylic Acid Derivatives and Their Use as Pharmaceuticals
Patent: 9,328,071 →
Application: 14/314,780 →
Publication: US US20140309264A1
Antibodies to Kallidin and Des-ARG9-Kallidin
Patent: 9,376,494 →
Application: 14/382,798 →
Publication: US US20150050270A1
Long-Acting Formulations of Insulin
Patent: 9,345,750 →
Application: 14/220,562 →
Publication: US US20140206611A1
Novel Thienopyrimidine Derivatives, Processes for the Preparation Thereof and Therapeutic Uses Thereof
Patent: 9,115,140 →
Application: 13/855,246 →
Publication: US US20130261106A1
Treatment of Diabetes Mellitus by Long-Acting Formulations of Insulins
Application: 14/781,857 →
Publication: US US20160030339A1
ROR GAMMA (RORy) MODULATORS
Application: 15/829,226 →
Publication: US US20180162808A1
Novel Thienopyrimidine Derivatives, Processes for the Preparation Thereof and Therapeutic Uses Thereof
Application: 16/245,131 →
Publication: US US20190151330A1
Therapeutic uses of novel thienopyrimidine derivatives
Patent: 9,744,176 →
Application: 14/794,574 →
Publication: US US20150352124A1
Novel Thienopyrimidine Derivatives, Processes for the Preparation Thereof and Therapeutic Uses Thereof
Application: 16/668,555 →
Publication: US US20200078370A1
Methods for Characterizing Compositions Comprising Peanut Antigens
Application: 16/580,638 →
Publication: US US20200116732A1
Measurement Probe for an Injection Device
Application: 17/052,244 →
Publication: US US20210170105A1
Derivatives of 7-Alkynyl-1,8-Naphthyridones, Preparation Method Thereof and Use of Same in Therapeutics
Patent: 8,263,614 →
Application: 12/631,130 →
Publication: US US20100144782A1
Process for the Preparation of Enantiomeric Forms of 2,3-Diaminopropionic Acid Derivatives
Patent: 8,877,926 →
Application: 13/763,975 →
Publication: US US20130211085A1
Stabilized Pharmaceutical Formulations of Insulin Analogues and/or Insulin Derivatives
Patent: 9,839,675 →
Application: 14/172,151 →
Publication: US US20140221285A1
Process for the Preparation of Enantiomeric Forms of 2,3-Diaminopropionic Acid Derivatives
Patent: 9,434,696 →
Application: 14/502,141 →
Publication: US US20150018554A1
Fused Pyrroledicarboxamides and Their Use as Pharmaceuticals
Patent: 9,884,860 →
Application: 15/041,541 →
Publication: US US20160159793A1
Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for Their Preparation and Therapeutic Uses Thereof
Patent: 9,714,221 →
Application: 15/432,470 →
Publication: US US20170233340A1
Substituted Pyrido[3,4-B]Indoles for the Treatment of Cartilage Disorders
Application: 16/347,386 →
Publication: US US20200095242A1
Bivalent, Bispecific Binding Proteins for Prevention or Treatment of Hiv Infection
Application: 16/659,426 →
Publication: US US20200054765A1
2-Amino-3-(Imidazol-2-Yl)-Pyridin-4-One Derivatives and Their Use as Vegf Receptor Kinase Inhibitors
Patent: 9,675,606 →
Application: 14/809,087 →
Publication: US US20150328205A1
Novel Thienopyrimidine Derivatives, Processes for the Preparation Thereof and Therapeutic Uses Thereof
Application: 15/660,694 →
Publication: US US20170319594A1
Antitumor Combinations Containing Antibodies Recognizing Specifically CD38 and Vincristine
Patent: 8,633,301 →
Application: 13/130,865 →
Publication: US US20110293606A1
Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
Patent: 9,221,917 →
Application: 13/804,965 →
Publication: US US20140056895A1
Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
Patent: 9,181,349 →
Application: 13/826,126 →
Publication: US US20140011238A1
Methods for Characterizing Compositions Comprising Peanut Antigens
Application: 15/392,233 →
Publication: US US20170219600A1
Anti-CEACAM5 Antibodies and Uses Thereof
Application: 16/558,939 →
Publication: US US20200102401A1
Treatment of Diabetes Mellitus by Long-Acting Formulations of Insulins
Application: 16/700,541 →
Publication: US US20200170945A1
Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for Their Preparation and Therapeutic Uses Thereof
Application: 17/124,852 →
Publication: US US20210323916A1
Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof
Application: 17/532,051 →
Publication: US US20220073460A1
Derivatives of 7-Alkynyl-1,8-Naphthyridones, Preparation Method Thereof and Use of Same in Therapeutics
Patent: 8,470,847 →
Application: 12/631,122 →
Publication: US US20100144757A1
2-Amino-3-(Imidazol-2-Yl)-Pyridin-4-One Derivatives and Their Use as Vegf Receptor Kinase Inhibitors
Patent: 9,126,972 →
Application: 14/117,750 →
Publication: US US20140094488A1
Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-Indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino) -ethyl ] -amide
Patent: 9,067,918 →
Application: 14/363,146 →
Publication: US US20140336211A1
Anti-CEACAM5 Antibodies and Uses Thereof
Patent: 9,617,345 →
Application: 14/716,377 →
Publication: US US20160108131A1
Drive Mechanism for a Drug Delivery Device
Application: 14/782,742 →
Publication: US US20160045666A1
Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof
Patent: 9,845,363 →
Application: 14/911,429 →
Publication: US US20160200831A1
Methods for Treating Pain Using Antibodies to Kallidin and Des-ARG10-Kallidin
Patent: 9,879,079 →
Application: 15/163,883 →
Publication: US US20160368976A1
Nucleic Acids Encoding Antibodies to Kallidin and Des-ARG10-Kallidin and Host Cells Comprising the Same
Application: 15/844,883 →
Publication: US US20180222967A1
Mixing and/or Reconstitution System
Application: 16/765,226 →
Publication: US US20200281815A1
Novel Thienopyrimidine Derivatives, Processes for the Preparation Thereof and Therapeutic Uses Thereof
Application: 16/915,782 →
Publication: US US20200323874A1
Bivalent, Bispecific Binding Proteins for Prevention or Treatment of Hiv Infection
Application: 17/404,908 →
Publication: US US20220226495A1
Composition Comprising Aflibercept, Folinic Acid, 5-Fluorouracil (5-Fu) and Irinotecan (Folfiri)
Application: 14/113,757 →
Publication: US US20140051642A1
Benzoic Acid Salt of Otamixaban
Patent: 8,993,602 →
Application: 14/008,332 →
Publication: US US20140024684A1
Method for Preparing Phenyloxymethyl-Nitro-Imidazole Derivatives and Use of Same
Patent: 9,758,488 →
Application: 14/647,017 →
Publication: US US20150291536A1
Anti-CEACAM5 Antibodies and Uses Thereof
Application: 15/446,465 →
Publication: US US20180022817A1
Combination Comprising Palbociclib and 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-Yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7] Annulene-2-Carboxylic Acid and Its Use for the Treatment of Cancer
Application: 16/634,089 →
Publication: US US20200171033A1
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
Application: 18/175,030 →
Publication: US US20230250105A1
Fused Pentacyclic Imidazole Derivatives
Application: 17/102,790 →
Publication: US US20210155637A1
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
Application: 17/176,018 →
Publication: US US20210252012A1
Methods for Treating or Preventing Asthma by Administering an Il-4R Antagonist
Patent: 9,574,004 →
Application: 13/971,334 →
Publication: US US20140056920A1
Methods for the Treatment of Rheumatoid Arthritis
Patent: 9,943,594 →
Application: 13/648,521 →
Publication: US US20130149310A1
Compositions for the Treatment of Rheumatoid Arthritis and Methods of Using Same
Application: 14/350,973 →
Publication: US US20140302053A1
Methods for Treating Nasal Polyposis by Administering an Il-4R Antagonist
Application: 14/310,419 →
Publication: US US20150017182A1
Methods for Treating or Preventing Asthma by Administering an Il-4R Antagonist
Application: 14/627,728 →
Publication: US US20150246119A1
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
Application: 16/497,217 →
Publication: US US20200046723A1
Fused Pentacyclic Imidazole Derivatives
Application: 16/220,847 →
Publication: US US20190367535A1
Fused Pentacyclic Imidazole Derivatives
Application: 15/513,357 →
Humidity Control in Chemical Reactors
Application: 17/897,489 →
Publication: US US20220411741A1
Humidity Control in Chemical Reactors
Application: 16/654,808 →
Publication: US US20200040298A1
Humidity Control in Chemical Reactors
Application: 14/064,021 →
Publication: US US20140120609A1
ROR GAMMA (RORy) MODULATORS
Application: 16/710,782 →
Publication: US US20200190028A1
Novel Anti-CD38 Antibodies for the Treatment of Cancer
Patent: 8,153,765 →
Application: 12/441,466 →
Publication: US US20090304710A1
Novel Anti-CD38 Antibodies for the Treatment of Cancer
Application: 16/784,577 →
Publication: US US20200408765A1
Auto-Injector
Patent: 9,375,532 →
Application: 14/352,357 →
Publication: US US20140243751A1
Detent Mechanism for a Medicament Delivery Device
Application: 14/395,997 →
Publication: US US20150088077A1
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 23, 2013
From: SCHAEFER, MATTHIAS; PERNERSTORFER, JOSEF; KADEREIT, DIETER; STROBEL, HARTMUT
To: SANOFI-AVENTIS
Reel/Frame 031067/0269 →
Change of Name Aug 26, 2013
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 031077/0960 →
Assignment of Assignor's Interest Oct 19, 2014
From: BIALY, LAURENT; LORENZ, KATRIN; WIRTH, KLAUS; STEINMEYER, KLAUS
To: SANOFI
Reel/Frame 033977/0429 →
Assignment of Assignor's Interest May 21, 2015
From: DECKERT, JUTTA; MAYO, MICHELE F; PARK, PETER U
To: IMMUNOGEN, INC.
Reel/Frame 035690/0014 →
Assignment of Assignor's Interest May 21, 2015
From: IMMUNOGEN, INC.
To: SANOFI
Reel/Frame 035690/0102 →
Assignment of Assignor's Interest May 21, 2015
From: LEJEUNE, PASCALE
To: SANOFI
Reel/Frame 035689/0415 →
Assignment of Assignor's Interest Sep 12, 2017
From: BOUABOULA, MONSIF; BROLLO, MAURICE; CERTAL, VICTOR; EL-AHMAD, YOUSSEF
To: SANOFI
Reel/Frame 043551/0473 →
Assignment of Assignor's Interest Mar 15, 2021
From: BAURIN, NICOLAS; BEIL, CHRISTIAN; CORVEY, CARSTEN; LANGE, CHRISTIAN
To: SANOFI
Reel/Frame 055587/0418 →
Assignment of Assignor's Interest Sep 7, 2021
From: GRETZKE, DIRK; RITZELER, OLAF; HEINELT, UWE; WEHNER, VOLKMAR
To: SANOFI
Reel/Frame 057402/0867 →
Assignment of Assignor's Interest Feb 10, 2022
From: SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
To: SANOFI
Reel/Frame 058974/0647 →
Assignment of Assignor's Interest Feb 10, 2022
From: SANOFI WINTHROP INDUSTRIE
To: SANOFI
Reel/Frame 058974/0598 →
Assignment of Assignor's Interest Feb 10, 2022
From: RABION, ALAIN
To: SANOFI WINTHROP INDUSTRIE
Reel/Frame 058974/0608 →
Assignment of Assignor's Interest Feb 10, 2022
From: TABART, MICHEL; WEHREY, CHRISTIAN
To: SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
Reel/Frame 058974/0753 →
Assignment of Assignor's Interest Nov 29, 2022
From: MALPART, JOËL; RUIZ-MONTES, JOSÉ
To: SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
Reel/Frame 061910/0706 →
Assignment of Assignor's Interest Nov 29, 2022
From: SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
To: SANOFI
Reel/Frame 061911/0657 →
Assignment of Assignor's Interest Oct 5, 2023
From: XU, LING; BENINGA, JOCHEN; KRUIP, JOCHEN; RAO, ERCOLE
To: SANOFI
Reel/Frame 065141/0422 →
Assignment of Assignor's Interest Oct 5, 2023
From: NABEL, GARY J.; YANG, ZHI-YONG
To: SANOFI
Reel/Frame 065141/0400 →
Assignment of Assignor's Interest Aug 7, 2024
From: JANIAK, PHILIP; MORGAN, CHRISTOPHER RYAN; BAURIN, NICOLAS; GRAILHE, PATRICK
To: SANOFI
Reel/Frame 068211/0722 →
Assignment of Assignor's Interest Aug 16, 2024
From: LI, HAN; KOMINOS, DOROTHEA; ZHANG, JIE; PRITSKER, ALLA
To: SANOFI
Reel/Frame 068317/0692 →
Assignment of Assignor's Interest Aug 26, 2024
From: BERNE, PIERRE-FRANCOIS; BLANCHE, FRANCIS; BOUCHARD, HERVÉ; CAMERON, BÉATRICE
To: SANOFI
Reel/Frame 068402/0156 →